http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100411195-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1676 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 |
| filingDate | 2000-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100411195-B1 |
| titleOfInvention | Controlled release of ketorolac tromethamine using pellet-tape dosage form |
| abstract | The present invention relates to sustained-release pellets containing ketorolac tromethamine, and more particularly, to the drug-containing endothelial layer containing the crystalline nucleus, ketorolac tromethamine drug, and ketorollac tromethamine drug and drug release. As a regulating mechanism, it is composed of a drug-containing sustained-release outer skin layer containing Eudragit, which increases the initial release rate to enhance the anti-inflammatory analgesic effect, and gradually releases the drug. The present invention relates to a sustained-release pellet containing ketorolac tromethamine that can alleviate and reduce the number of daily doses to increase medication compliance. |
| priorityDate | 2000-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.